Incyte and Genesis Therapeutics Announce Strategic AI-focused Research Collaboration
Go back to Incyte and Genesis Therapeutics Announce Strategic AI-focused Research Collaboration| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 123.20 -1.62 (1.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.82 | 52 Week High | $118.49 | |||
| Open | $123.67 | 52 Week Low | $55.00 | |||
| Day High | $125.47 | P/E | N/A | |||
| Day Low | $121.89 | EPS | $-0.56 | |||
| Volume | 1,718,562 | |||||
